113 related articles for article (PubMed ID: 10863186)
1. [Mupirocin: its use].
Janin N; Mignon A
Ann Dermatol Venereol; 2000 May; 127(5):517-8. PubMed ID: 10863186
[No Abstract] [Full Text] [Related]
2. Association between nasal methicillin-resistant Staphylococcus aureus carriage and infection in liver transplant recipients.
Patel R
Liver Transpl; 2001 Aug; 7(8):752-3. PubMed ID: 11780649
[No Abstract] [Full Text] [Related]
3. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention.
Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538
[TBL] [Abstract][Full Text] [Related]
4. Mupirocin to prevent S. aureus infections.
Farr BM
N Engl J Med; 2002 Jun; 346(24):1905-6. PubMed ID: 12063377
[No Abstract] [Full Text] [Related]
5. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.
Paterson DL; Rihs JD; Squier C; Gayowski T; Sagnimeni A; Singh N
Transplantation; 2003 Jan; 75(2):194-8. PubMed ID: 12548122
[TBL] [Abstract][Full Text] [Related]
6. Intranasal mupirocin to prevent postoperative infections.
von Eiff C; Kipp F; Becker K
N Engl J Med; 2002 Oct; 347(15):1207-8; author reply 1207-8. PubMed ID: 12374887
[No Abstract] [Full Text] [Related]
7. [Methicillin-resistant Staphylococcus aureus infection in a geriatric unit for acutely ill].
Selva O'Callaghan A; San José Laporte A; Almirante Gragera B; Vilardell Tarrés M
Med Clin (Barc); 1998 May; 110(17):678. PubMed ID: 9656216
[No Abstract] [Full Text] [Related]
8. [How promising is decontamination treatment of MRSA carriers?].
Panknin HT
Med Monatsschr Pharm; 2007 Mar; 30(3):114-5. PubMed ID: 17405489
[No Abstract] [Full Text] [Related]
9. Staphylococcus aureus decolonization.
Chen SF
Pediatr Infect Dis J; 2005 Jan; 24(1):79-80. PubMed ID: 15665714
[No Abstract] [Full Text] [Related]
10. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.
Jones JC; Rogers TJ; Brookmeyer P; Dunne WM; Storch GA; Coopersmith CM; Fraser VJ; Warren DK
Clin Infect Dis; 2007 Sep; 45(5):541-7. PubMed ID: 17682986
[TBL] [Abstract][Full Text] [Related]
11. Prevention of Staphylococcus aureus burn wound colonization by nasal mupirocin.
Kooistra-Smid AM; van Zanten E; Ott A; van Dijk SR; Beerthuizen GI; Vogels WH; van Belkum A; Verbrugh HA
Burns; 2008 Sep; 34(6):835-9. PubMed ID: 18242873
[TBL] [Abstract][Full Text] [Related]
12. Treatment of impetigo: save mupirocin.
Axelsson I
BMJ; 2004 Oct; 329(7472):979. PubMed ID: 15499129
[No Abstract] [Full Text] [Related]
13. Decrease in Staphylococcus aureus surgical site infections following cardiovascular surgery.
Coskun D; Aytac J
J Hosp Infect; 2005 Jul; 60(3):287-9. PubMed ID: 15949622
[No Abstract] [Full Text] [Related]
14. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
[TBL] [Abstract][Full Text] [Related]
15. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG
Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881
[TBL] [Abstract][Full Text] [Related]
16. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.
Muller A; Talon D; Potier A; Belle E; Cappelier G; Bertrand X
Crit Care; 2005 Jun; 9(3):R246-50. PubMed ID: 15987397
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus.
Harbarth S; Liassine N; Dharan S; Herrault P; Auckenthaler R; Pittet D
Clin Infect Dis; 2000 Dec; 31(6):1380-5. PubMed ID: 11096006
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin.
Alou L; Cafini F; Sevillano D; Unzueta I; Prieto J
Int J Antimicrob Agents; 2004 May; 23(5):513-6. PubMed ID: 15120734
[TBL] [Abstract][Full Text] [Related]
19. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
Dolapçi I; Karahan ZC; Tekeli A; Koyuncu E; Azap A; Adaleti R
Mikrobiyol Bul; 2007 Jul; 41(3):435-40. PubMed ID: 17933255
[TBL] [Abstract][Full Text] [Related]
20. Incidence and effect of incorrect prescription and administration of nasal mupirocin for methicillin-resistant Staphylococcus aureus.
Lines LD; Weightman NC
J Hosp Infect; 2005 Oct; 61(2):179-80. PubMed ID: 16002185
[No Abstract] [Full Text] [Related]
[Next] [New Search]
